A 59-year-old with new HFrEF (EF 28%) on ACE inhibitor and beta-blocker presents for optimization. HR 82/min, K+ 4.6 mEq/L, eGFR 70. Which mortality-r...

Question

A 59-year-old with new HFrEF (EF 28%) on ACE inhibitor and beta-blocker presents for optimization. HR 82/min, K+ 4.6 mEq/L, eGFR 70. Which mortality-reducing addition is indicated now?

Accepted Answer

Mineralocorticoid receptor antagonist

Answer

Ivabradine

Answer

Isosorbide dinitrate alone

Answer

Loop diuretic

Answer

Nifedipine ER

us-abim MCQ (SBA): Heart Failure with Reduced Ejection Fraction

A 59-year-old with new HFrEF (EF 28%) on ACE inhibitor and beta-blocker presents for optimization. HR 82/min, K+ 4.6 mEq/L, eGFR 70. Which mortality-reducing addition is indicated now?